Hydronidone capsules
Hydronidone capsules is a pharmaceutical drug with 8 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
2
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
5
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis
A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis
A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls
A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
Clinical Trials (8)
A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis
A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis
A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls
A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
The Phase Ⅰd Clinical Trial of Hydronidone Capsules
Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8